The Bureau of Labor Statistics releases the consumer price index for March. Economists forecast a 2.6% year-over-year increase, two-tenths of a percentage point less than in February. The core CPI, ...

A gauge of investor anxiety in the U.S. stock market has soared since President Trump announced reciprocal tariffs on April 2. The Cboe Volatility Index VIX surged 50.9% on Friday to 45.31, its ...

Here’s the updated list of Morningstar’s top underpriced analyst picks to buy during 2025’s second quarter.

Here are some of the major companies whose stocks moved on the week's news. StubHub and Klarna are postponing their IPO roadshows, and Chime is delaying plans. The Switch 2 will be coming on June 5, ...

I invested $100,000 in the S&P 500 in February and lost $10,000. How long will it take to recover? Dear Soon, You have 3 years or more before retirement. Plus, you should be earning returns on your ...

As if investors didn't have enough to worry about, they can now add an open breach between President Donald Trump and the chair of the Federal Reserve during an economic crisis and a financial ...

Expedia's recent share-repurchase activity appears more opportunistic than programmatic, with the company buying $1.6 billion worth at an average share price of $134 in 2024, which we view as positive ...

When my mother passed away, my younger brother, who lived with her, took care of her estate. She was always helping him with his bills. He was not forthcoming with me and our two older sisters. We did ...

Economists and consumers are, naturally perhaps, upping their own predictions of whether there will be a recession on the back of Trump's trade war. Polymarket, the U.S.-based crypto-based prediction ...

Maxeon Solar Technologies said it is establishing an alternative network of supply-chain partners and increasing its manufacturing capabilities in the U.S. as it deals with new tariffs and trade ...

The tariff hikes announced April 2, if maintained, represent a self-inflicted economic catastrophe for the US.

Shares of Eli Lilly, the seller of Zepbound, were down 2.7% to $718.50 after the close on Friday. Novo Nordisk, the maker of Wegovy, saw its stock decline 1.4% to $61.67. Shares of Hims & Hers, a ...